-
Effectiveness, safety and costs of labor induction with intravaginal misoprostol versus dinoprostone vaginal insert
Maria Asuncion Quijada Cazorla, Ana Maria Palacios Marques, Josefa Marcos Sanmartin, Eduardo Cazorla Amoros, Juan Carlos Martinez Escoriza
Research Paper: Clinical Investigation
-
Effectiveness, safety and costs of labor induction with intravaginal misoprostol versus dinoprostone vaginal insert
Maria Asuncion Quijada Cazorla, Ana Maria Palacios Marques, Josefa Marcos Sanmartin, Eduardo Cazorla Amoros, Juan Carlos Martinez Escoriza
Research Paper: Clinical Investigation
-
Effectiveness, safety and costs of labor induction with intravaginal misoprostol versus dinoprostone vaginal insert
Maria Asuncion Quijada Cazorla, Ana Maria Palacios Marques, Josefa Marcos Sanmartin, Eduardo Cazorla Amoros, Juan Carlos Martinez Escoriza
Research Paper: Clinical Investigation
-
Effectiveness, safety and costs of labor induction with intravaginal misoprostol versus dinoprostone vaginal insert
Maria Asuncion Quijada Cazorla, Ana Maria Palacios Marques, Josefa Marcos Sanmartin, Eduardo Cazorla Amoros, Juan Carlos Martinez Escoriza
Research Paper: Clinical Investigation
-
Effectiveness, safety and costs of labor induction with intravaginal misoprostol versus dinoprostone vaginal insert
Maria Asuncion Quijada Cazorla, Ana Maria Palacios Marques, Josefa Marcos Sanmartin, Eduardo Cazorla Amoros, Juan Carlos Martinez Escoriza
Research Paper: Clinical Investigation
-
Effectiveness, safety and costs of labor induction with intravaginal misoprostol versus dinoprostone vaginal insert
Maria Asuncion Quijada Cazorla, Ana Maria Palacios Marques, Josefa Marcos Sanmartin, Eduardo Cazorla Amoros, Juan Carlos Martinez Escoriza
Research Paper: Clinical Investigation
-
Effectiveness, safety and costs of labor induction with intravaginal misoprostol versus dinoprostone vaginal insert
Maria Asuncion Quijada Cazorla, Ana Maria Palacios Marques, Josefa Marcos Sanmartin, Eduardo Cazorla Amoros, Juan Carlos Martinez Escoriza
Research Paper: Clinical Investigation
-
Effectiveness, safety and costs of labor induction with intravaginal misoprostol versus dinoprostone vaginal insert
Maria Asuncion Quijada Cazorla, Ana Maria Palacios Marques, Josefa Marcos Sanmartin, Eduardo Cazorla Amoros, Juan Carlos Martinez Escoriza
Research Paper: Clinical Investigation
-
The role of meta-analysis in defining clinical practice in advanced non-small-cell lung cancer
Massimo Di Maio
Therapeutic Prospective: Clinical Investigation
-
The role of meta-analysis in defining clinical practice in advanced non-small-cell lung cancer
Massimo Di Maio
Therapeutic Prospective: Clinical Investigation
-
The role of meta-analysis in defining clinical practice in advanced non-small-cell lung cancer
Massimo Di Maio
Therapeutic Prospective: Clinical Investigation
-
The role of meta-analysis in defining clinical practice in advanced non-small-cell lung cancer
Massimo Di Maio
Therapeutic Prospective: Clinical Investigation
-
The role of meta-analysis in defining clinical practice in advanced non-small-cell lung cancer
Massimo Di Maio
Therapeutic Prospective: Clinical Investigation
-
The role of meta-analysis in defining clinical practice in advanced non-small-cell lung cancer
Massimo Di Maio
Therapeutic Prospective: Clinical Investigation
-
The role of meta-analysis in defining clinical practice in advanced non-small-cell lung cancer
Massimo Di Maio
Therapeutic Prospective: Clinical Investigation
-
The role of meta-analysis in defining clinical practice in advanced non-small-cell lung cancer
Massimo Di Maio
Therapeutic Prospective: Clinical Investigation
-
Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches
Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe
Review: Clinical Trail Outcomes: Clinical Investigation
-
Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches
Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe
Review: Clinical Trail Outcomes: Clinical Investigation
-
Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches
Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe
Review: Clinical Trail Outcomes: Clinical Investigation
-
Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches
Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe
Review: Clinical Trail Outcomes: Clinical Investigation
-
Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches
Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe
Review: Clinical Trail Outcomes: Clinical Investigation
-
Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches
Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe
Review: Clinical Trail Outcomes: Clinical Investigation
-
Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches
Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe
Review: Clinical Trail Outcomes: Clinical Investigation
-
Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches
Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe
Review: Clinical Trail Outcomes: Clinical Investigation
-
Endocrine resistance: mechanisms and therapeutic targets
Senthil Damodaran, Sarmila Majumder, Bhuvaneswari Ramaswamy
Review: Clinical Trail Outcomes: Clinical Investigation
-
Endocrine resistance: mechanisms and therapeutic targets
Senthil Damodaran, Sarmila Majumder, Bhuvaneswari Ramaswamy
Review: Clinical Trail Outcomes: Clinical Investigation
-
Endocrine resistance: mechanisms and therapeutic targets
Senthil Damodaran, Sarmila Majumder, Bhuvaneswari Ramaswamy
Review: Clinical Trail Outcomes: Clinical Investigation
-
Endocrine resistance: mechanisms and therapeutic targets
Senthil Damodaran, Sarmila Majumder, Bhuvaneswari Ramaswamy
Review: Clinical Trail Outcomes: Clinical Investigation
-
Endocrine resistance: mechanisms and therapeutic targets
Senthil Damodaran, Sarmila Majumder, Bhuvaneswari Ramaswamy
Review: Clinical Trail Outcomes: Clinical Investigation
-
Endocrine resistance: mechanisms and therapeutic targets
Senthil Damodaran, Sarmila Majumder, Bhuvaneswari Ramaswamy
Review: Clinical Trail Outcomes: Clinical Investigation
-
Endocrine resistance: mechanisms and therapeutic targets
Senthil Damodaran, Sarmila Majumder, Bhuvaneswari Ramaswamy
Review: Clinical Trail Outcomes: Clinical Investigation
-
Endocrine resistance: mechanisms and therapeutic targets
Senthil Damodaran, Sarmila Majumder, Bhuvaneswari Ramaswamy
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation